{"id":"placebo-preventative","safety":{"commonSideEffects":[{"rate":null,"effect":"No adverse events"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"As a placebo, it does not interact with any biological molecules or systems, and its effects are purely psychological or due to the natural course of the disease. The lack of therapeutic effect is intentional, allowing researchers to compare outcomes against a control group.","oneSentence":"This drug is a placebo, meaning it has no active therapeutic effect.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:51:46.579Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prevention of symptoms in clinical trials"}]},"trialDetails":[{"nctId":"NCT03354741","phase":"NA","title":"Stimulation of Acupuncture Points by Athermic Laser Therapy for the Prevention of Chemotherapy Induced Nausea and Vomiting in Children","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Nice","startDate":"2019-05-23","conditions":"Children, Chemotherapy-induced Nausea and Vomiting, Malignant Tumor","enrollment":30},{"nctId":"NCT04628026","phase":"PHASE3","title":"Phase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Patients With Newly Diagnosed AML or MDS-EB-2","status":"RECRUITING","sponsor":"University of Ulm","startDate":"2022-09-13","conditions":"Acute Myeloid Leukemia","enrollment":650},{"nctId":"NCT04235816","phase":"PHASE3","title":"Improving Care Through Azithromycin Research for Infants in Africa","status":"ACTIVE_NOT_RECRUITING","sponsor":"Barcelona Institute for Global Health","startDate":"2021-03-15","conditions":"Child Mortality","enrollment":20560},{"nctId":"NCT05419011","phase":"PHASE2","title":"Testing a Combination of Vaccines for Cancer Prevention in Lynch Syndrome","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2023-05-08","conditions":"Colorectal Carcinoma, Colorectal Neoplasm, Lynch Syndrome","enrollment":186},{"nctId":"NCT07495995","phase":"PHASE2","title":"Single-Center Phase II Double-Blind Trial of SAMe to Prevent Liver Cancer in MASLD-Related Cirrhosis","status":"NOT_YET_RECRUITING","sponsor":"Cedars-Sinai Medical Center","startDate":"2026-04-15","conditions":"Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)","enrollment":94},{"nctId":"NCT01113229","phase":"PHASE4","title":"Combined Use of Oxytocin and Misoprostol in the Prevention of Post Partum Haemorrhage","status":"TERMINATED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2010-03","conditions":"Hemorrhage; Complicating Delivery","enrollment":1721},{"nctId":"NCT04939051","phase":"PHASE2","title":"Obeticholic Acid for Prevention in Barrett's Esophagus","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2024-01-03","conditions":"Barrett Esophagus, Esophageal Adenocarcinoma","enrollment":30},{"nctId":"NCT07498517","phase":"PHASE2","title":"Safety and Efficacy of a Single Dose of Gruticibart to Prevent CRT","status":"NOT_YET_RECRUITING","sponsor":"OHSU Knight Cancer Institute","startDate":"2026-02-28","conditions":"Thrombosis","enrollment":90},{"nctId":"NCT07284316","phase":"PHASE2, PHASE3","title":"Effect of a Multidomain Intervention Plus Turmeric on the Prevention of Cognitive Decline in People Over 55 Years of Age With Insulin Resistance.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Instituto Mexicano del Seguro Social","startDate":"2025-02-20","conditions":"Cognitive Decline, Subjective Cognitive Impairment, Insulin Resistance","enrollment":100},{"nctId":"NCT04580472","phase":"PHASE4","title":"Utility of Single-dose Oral Antibiotic Prophylaxis in Prevention of Surgical Site Infection in Dermatologic Surgery","status":"ACTIVE_NOT_RECRUITING","sponsor":"Carilion Clinic","startDate":"2020-10-01","conditions":"Surgical Site Infection","enrollment":574},{"nctId":"NCT05447559","phase":"PHASE4","title":"Duration of Cardiac Antimicrobial Prophylaxis Outcomes Study","status":"RECRUITING","sponsor":"Monash University","startDate":"2023-02-07","conditions":"Surgical Site Infection","enrollment":9180},{"nctId":"NCT07300085","phase":"PHASE1","title":"A Trial to Evaluate the Effect of CD388 on the Immunogenicity of Fluzone® HD Vaccine","status":"ACTIVE_NOT_RECRUITING","sponsor":"Cidara Therapeutics Inc.","startDate":"2025-11-08","conditions":"Healthy Participants","enrollment":100},{"nctId":"NCT05511363","phase":"PHASE3","title":"A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)","status":"RECRUITING","sponsor":"Karuna Therapeutics, Inc., a Bristol Myers Squibb company","startDate":"2022-08-23","conditions":"Psychosis Associated With Alzheimer's Disease","enrollment":410},{"nctId":"NCT07362446","phase":"PHASE2","title":"Prevention of Reperfusion Injury Outcomes Through Effective Cardioprotection Targeting Myocardial Infarction","status":"NOT_YET_RECRUITING","sponsor":"Nyrada Pty Ltd","startDate":"2026-04-16","conditions":"Myocardial Infarction, Reperfusion Injury, AMI","enrollment":300},{"nctId":"NCT05677763","phase":"PHASE4","title":"OM-85 in Paediatric Recurrent Respiratory Tract Infections With Wheezing Lower Respiratory Illness","status":"ACTIVE_NOT_RECRUITING","sponsor":"OM Pharma SA","startDate":"2022-12-12","conditions":"Respiratory Tract Infections, Wheezing Lower Respiratory Illness","enrollment":525},{"nctId":"NCT07486921","phase":"PHASE2","title":"Etrasimod as Prevention of Pouchitis","status":"NOT_YET_RECRUITING","sponsor":"Maia Kayal","startDate":"2026-03","conditions":"Pouchitis","enrollment":40},{"nctId":"NCT05610800","phase":"PHASE2","title":"Exenatide for Smoking Cessation and Prevention of Weight Gain","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2022-12-07","conditions":"Smoking Cessation, Weight Gain","enrollment":140},{"nctId":"NCT05075824","phase":"PHASE2","title":"A Study Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Crovalimab as Adjunct Treatment in Prevention of Vaso-Occlusive Episodes (VOE) in Sickle Cell Disease (SCD)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hoffmann-La Roche","startDate":"2022-03-09","conditions":"Sickle Cell Disease","enrollment":90},{"nctId":"NCT07488988","phase":"PHASE2","title":"SCARFREE-001: Verteporfin for Scar Prevention","status":"NOT_YET_RECRUITING","sponsor":"Odense University Hospital","startDate":"2026-06","conditions":"Surgical Scar","enrollment":12},{"nctId":"NCT07236814","phase":"PHASE3","title":"Suraxavir Marboxil And Oseltamivir for Influenza Prophylaxis Under a Hospital-based Setting","status":"RECRUITING","sponsor":"Capital Medical University","startDate":"2025-11-28","conditions":"Influenza","enrollment":384},{"nctId":"NCT06909565","phase":"PHASE4","title":"Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention","status":"RECRUITING","sponsor":"Duke University","startDate":"2025-07-23","conditions":"Percutaneous Coronary Intervention, Peripheral Endovascular Intervention","enrollment":6000},{"nctId":"NCT07018700","phase":"PHASE3","title":"A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine","status":"RECRUITING","sponsor":"Merz Therapeutics GmbH","startDate":"2025-08-21","conditions":"Episodic Migraine","enrollment":990},{"nctId":"NCT07018713","phase":"PHASE3","title":"A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine","status":"RECRUITING","sponsor":"Merz Therapeutics GmbH","startDate":"2025-08-21","conditions":"Chronic Migraine","enrollment":780},{"nctId":"NCT07071623","phase":"PHASE3","title":"A Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-010)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2025-11-10","conditions":"Human Immunodeficiency Virus (HIV), HIV Pre-Exposure Prophylaxis","enrollment":4580},{"nctId":"NCT05156398","phase":"PHASE3","title":"Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects","status":"RECRUITING","sponsor":"Pfizer","startDate":"2022-02-28","conditions":"Migraine","enrollment":640},{"nctId":"NCT05405387","phase":"PHASE2","title":"Impact of Budesonide on Incidence of ≥ Gr2 Diarrhea in Multiple Myeloma (MM) Patients Undergoing Autologous Stem Cell Transplant","status":"RECRUITING","sponsor":"University of Utah","startDate":"2023-05-03","conditions":"Multiple Myeloma, Plasma Cell Leukemia","enrollment":120},{"nctId":"NCT06641466","phase":"PHASE3","title":"A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine","status":"RECRUITING","sponsor":"Pfizer","startDate":"2025-03-11","conditions":"Menstrual Migraine","enrollment":723},{"nctId":"NCT07044297","phase":"PHASE3","title":"A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2025-07-31","conditions":"Human Immunodeficiency Virus (HIV), HIV Pre-Exposure Prophylaxis","enrollment":4390},{"nctId":"NCT05711394","phase":"PHASE3","title":"A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine","status":"RECRUITING","sponsor":"AbbVie","startDate":"2023-05-01","conditions":"Episodic Migraine","enrollment":450},{"nctId":"NCT05097287","phase":"PHASE4","title":"Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Adult Patients With Uncontrolled Moderate to Severe Asthma","status":"RECRUITING","sponsor":"Sanofi","startDate":"2021-12-16","conditions":"Asthma","enrollment":1324},{"nctId":"NCT05227001","phase":"PHASE1","title":"A Study To Learn About The Study Vaccine (Called Self-Amplifying Ribonucleic Acid (RNA)) For The Prevention of Influenza","status":"COMPLETED","sponsor":"Pfizer","startDate":"2022-04-28","conditions":"Influenza, Human","enrollment":440},{"nctId":"NCT06237452","phase":"PHASE3","title":"VE303 for Prevention of Recurrent Clostridioides Difficile Infection","status":"RECRUITING","sponsor":"Vedanta Biosciences, Inc.","startDate":"2024-05-20","conditions":"Clostridium Difficile, Clostridium Difficile Infections, Clostridium Difficile Infection Recurrence","enrollment":852},{"nctId":"NCT04924166","phase":"PHASE2","title":"PTSD Prevention Using Oral Hydrocortisone","status":"COMPLETED","sponsor":"Rachel Yehuda","startDate":"2022-01-12","conditions":"PTSD, Acute Stress Disorder, Trauma-related Stressor","enrollment":201},{"nctId":"NCT06732388","phase":"PHASE2","title":"Itraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's Esophagus","status":"NOT_YET_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2026-02-16","conditions":"Barrett Esophagus, Clinical Stage I Esophageal Adenocarcinoma AJCC v8, Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8","enrollment":64},{"nctId":"NCT02720094","phase":"PHASE2, PHASE3","title":"Injectable Cabotegravir Compared to TDF/FTC For PrEP in HIV-Uninfected Men and Transgender Women Who Have Sex With Men","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2016-12-19","conditions":"HIV Infections","enrollment":4570},{"nctId":"NCT00856947","phase":"PHASE1","title":"Vitamin D Supplementation During Pregnancy for Prevention of Asthma in Childhood","status":"ACTIVE_NOT_RECRUITING","sponsor":"Copenhagen Studies on Asthma in Childhood","startDate":"2009-03","conditions":"Asthma","enrollment":600},{"nctId":"NCT07482540","phase":"NA","title":"Role of Dexmedatomidine Drug in Prevention of Atrial Fibrillations Post Mitral Valve Surgery","status":"NOT_YET_RECRUITING","sponsor":"Ain Shams University","startDate":"2026-06-01","conditions":"New Onset, Atrial Fibrillation","enrollment":140},{"nctId":"NCT04957719","phase":"PHASE3","title":"Selatogrel Outcome Study in Suspected Acute Myocardial Infarction","status":"ENROLLING_BY_INVITATION","sponsor":"Viatris Innovation GmbH","startDate":"2021-08-14","conditions":"Acute Myocardial Infarction","enrollment":14000},{"nctId":"NCT05842395","phase":"PHASE4","title":"Vitamin c Supplementation in the Prevention of CRPS Following Distal Radius Fractures","status":"COMPLETED","sponsor":"Damascus University","startDate":"2023-06-15","conditions":"Distal Radius Fracture, Vitamine c, Prophylaxis","enrollment":220},{"nctId":"NCT07479056","phase":"NA","title":"Randomized Active-Controlled Trial Evaluating Fexuprazan (Fexuclue Tab) for Prevention Upper Gastrointestinal Bleeding in High Bleeding Risk Patients Receiving Dual Antiplatelet Therapy After Coronary Intervention","status":"RECRUITING","sponsor":"SUK MIN SEO","startDate":"2024-10-24","conditions":"Diseases of the Circulatory System, Angina Pectoris, Unspecified","enrollment":400},{"nctId":"NCT07479394","phase":"PHASE4","title":"Impact of AHCC® Supplementation for Prevention of Respiratory Tract Infections Among Children Age 2-4 Years Old","status":"NOT_YET_RECRUITING","sponsor":"Hasanuddin University","startDate":"2026-06-01","conditions":"Respiratory Tract Infections (RTI)","enrollment":60},{"nctId":"NCT07410117","phase":"PHASE3","title":"REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis","status":"RECRUITING","sponsor":"Regeneron Pharmaceuticals","startDate":"2026-03-09","conditions":"Cancer-Associated Thrombosis (CAT)","enrollment":860},{"nctId":"NCT05547464","phase":"PHASE1, PHASE2","title":"Safety and Immune Responses After Vaccination With Two Investigational RNA-based Vaccines Against Tuberculosis in BCG Vaccinated Volunteers","status":"ACTIVE_NOT_RECRUITING","sponsor":"BioNTech SE","startDate":"2023-07-31","conditions":"Tuberculosis","enrollment":497},{"nctId":"NCT07213778","phase":"PHASE3","title":"REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Participants","status":"RECRUITING","sponsor":"Regeneron Pharmaceuticals","startDate":"2025-11-24","conditions":"Symptomatic Venous Thromboembolism (VTE)","enrollment":2000},{"nctId":"NCT07473128","phase":"PHASE3","title":"Effect of Trilaciclib in the Prevention of Myelosupression in Subjects With Limited-stage Small Cell Lung Cancer","status":"NOT_YET_RECRUITING","sponsor":"Pharmacosmos A/S","startDate":"2026-03-31","conditions":"Limited Stage Small Cell Lung Cancer","enrollment":120},{"nctId":"NCT07467707","phase":"PHASE3","title":"An Efficacy, Safety, and Immunogenicity Study of CHIKV VLP Vaccine for the Prevention of Chikungunya Disease in Adolescents and Adults","status":"NOT_YET_RECRUITING","sponsor":"Bavarian Nordic","startDate":"2026-05","conditions":"Chikungunya Virus","enrollment":6144},{"nctId":"NCT07298434","phase":"PHASE3","title":"Study of VYD2311 for the Prevention of COVID-19","status":"ACTIVE_NOT_RECRUITING","sponsor":"Invivyd, Inc.","startDate":"2026-01-08","conditions":"COVID-19","enrollment":1770},{"nctId":"NCT04791579","phase":"PHASE2","title":"Antibiotic Prophylaxis for Neurogenic Bladder Botox","status":"RECRUITING","sponsor":"University of Alberta","startDate":"2025-02-01","conditions":"Neurogenic Bladder, Post-operative Urinary Tract Infections","enrollment":160},{"nctId":"NCT07475546","phase":"PHASE3","title":"Combination Gerotherapeutic Interventions for Healthspan Improvement","status":"ACTIVE_NOT_RECRUITING","sponsor":"AgelessRx","startDate":"2025-07-23","conditions":"Healthspan Improvement, Aging, Longevity","enrollment":30},{"nctId":"NCT05886816","phase":"PHASE2","title":"Mitoquinone/Mitoquinol Mesylate as Oral and Safe Postexposure Prophylaxis for Covid-19","status":"RECRUITING","sponsor":"University of Texas Southwestern Medical Center","startDate":"2024-03-01","conditions":"SARS-CoV Infection, COVID-19","enrollment":112},{"nctId":"NCT07474077","phase":"PHASE3","title":"Investigating the Efficacy of Tranexamic Acid as a Prophylactic Agent in Reducing Postpartum Hemorrhage Among Patients Undergoing Cesarean Section in SQUH","status":"NOT_YET_RECRUITING","sponsor":"Sultan Qaboos University","startDate":"2026-05-01","conditions":"Post Partum Haemorrhage","enrollment":88},{"nctId":"NCT05739383","phase":"PHASE3","title":"A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2023-03-09","conditions":"Primary Prevention of Atherosclerotic Cardiovascular Disease","enrollment":14078},{"nctId":"NCT04459117","phase":"PHASE2, PHASE3","title":"Prophylactic Treatment of the Ductus Arteriosus in Preterm Infants by Acetaminophen","status":"COMPLETED","sponsor":"Institut National de la Santé Et de la Recherche Médicale, France","startDate":"2020-10-29","conditions":"Patency of the Ductus Arteriosus, Acetaminophen, Extreme Prematurity","enrollment":804},{"nctId":"NCT06861010","phase":"PHASE3","title":"Evaluating the Safety and Efficacy of Ondansetron in the Prevention of Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis","status":"RECRUITING","sponsor":"Tanta University","startDate":"2025-03-01","conditions":"Pancreatic Diseases","enrollment":44},{"nctId":"NCT05811351","phase":"PHASE2","title":"A Study to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2023-03-06","conditions":"Geographic Atrophy","enrollment":305},{"nctId":"NCT05702034","phase":"PHASE3","title":"A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE","status":"RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2023-02-15","conditions":"Ischemic Stroke; Ischemic Attack, Transient","enrollment":15000},{"nctId":"NCT04965675","phase":"PHASE3","title":"A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine","status":"RECRUITING","sponsor":"H. Lundbeck A/S","startDate":"2021-06-30","conditions":"Chronic Migraine in Children","enrollment":285},{"nctId":"NCT06382948","phase":"PHASE3","title":"Elacestrant + Everolimus in Patients ER+/HER2-, ESR1mut, Advanced Breast Cancer Progressing to ET and CDK4/6i.","status":"RECRUITING","sponsor":"MedSIR","startDate":"2024-12-05","conditions":"Advanced Breast Cancer, ER-positive Breast Cancer, HER2-negative Breast Cancer","enrollment":240},{"nctId":"NCT05897320","phase":"PHASE3","title":"A Study of Eptinezumab in Pediatric Participants With Episodic Migraine","status":"RECRUITING","sponsor":"H. Lundbeck A/S","startDate":"2023-06-08","conditions":"Episodic Migraine","enrollment":315},{"nctId":"NCT07468448","phase":"PHASE3","title":"Combination Antithrombotic Treatment for Prevention of Recurrent Ischemic Stroke in IntraCranial Atherosclerotic diseaSe (CATIS- ICAS)","status":"NOT_YET_RECRUITING","sponsor":"Population Health Research Institute","startDate":"2026-05-30","conditions":"Ischemic Stroke, Intracranial Atherosclerosis","enrollment":1172},{"nctId":"NCT06635135","phase":"PHASE3","title":"A Study of Aticaprant Plus an Antidepressant to Prevent Return of Depression Symptoms in Participants With Major Depressive Disorder Who Experience a Loss of Interest and Pleasure","status":"TERMINATED","sponsor":"Janssen Research & Development, LLC","startDate":"2024-09-19","conditions":"Depressive Disorder, Major, Anhedonia","enrollment":47},{"nctId":"NCT06488781","phase":"PHASE2","title":"Antibiotic Prophylaxis to Prevent Obesity-Related Induction Complications in Nulliparae at Term 2.0","status":"RECRUITING","sponsor":"University of Oklahoma","startDate":"2025-04-29","conditions":"Obesity in Pregnancy, Labor Complication","enrollment":787},{"nctId":"NCT07016750","phase":"PHASE3","title":"A Study Comparing KB803 and Matched Placebo in Patients With Dystrophic Epidermolysis Bullosa","status":"RECRUITING","sponsor":"Krystal Biotech, Inc.","startDate":"2025-06-20","conditions":"Dystrophic Epidermolysis Bullosa, DEB - Dystrophic Epidermolysis Bullosa, Recessive Dystrophic Epidermolysis Bullosa","enrollment":16},{"nctId":"NCT07463339","phase":"PHASE2","title":"Microbiome-guided Prophylaxis to Reduce Ventilator-Associated Pneumonia in Intensive Care Units: A Pilot Randomized Controlled Trial","status":"NOT_YET_RECRUITING","sponsor":"University of Calgary","startDate":"2026-05-01","conditions":"Critical Illness, Mechanical Ventilation","enrollment":70},{"nctId":"NCT07464392","phase":"NA","title":"FMT for the Prevention of Infectious Complications in Patients With Moderately Severe and Severe Acute Pancreatitis","status":"NOT_YET_RECRUITING","sponsor":"Changhai Hospital","startDate":"2026-03-01","conditions":"Acute Pancreatitis","enrollment":150},{"nctId":"NCT06825416","phase":"PHASE3","title":"A Clinical Study of SHR-2004 Injection in Preventing Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty","status":"ACTIVE_NOT_RECRUITING","sponsor":"Beijing Suncadia Pharmaceuticals Co., Ltd","startDate":"2025-03-16","conditions":"Prevention of Arterial and Venous Thrombosis","enrollment":1166},{"nctId":"NCT07285213","phase":"PHASE2","title":"Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Antibody","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2025-12-10","conditions":"Clostridioides Difficile Infection","enrollment":230},{"nctId":"NCT06059391","phase":"PHASE2","title":"CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant","status":"RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2024-07-12","conditions":"Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia","enrollment":216},{"nctId":"NCT06250283","phase":"NA","title":"Resveratrol for the Prevention of Bone Loss in Postmenopausal Women","status":"COMPLETED","sponsor":"University of Delaware","startDate":"2024-02-02","conditions":"Low Bone Mass","enrollment":52},{"nctId":"NCT02518594","phase":"PHASE3","title":"A Trial of Pessary and Progesterone for Preterm Prevention in Twin Gestation With a Short Cervix","status":"COMPLETED","sponsor":"The George Washington University Biostatistics Center","startDate":"2015-11-13","conditions":"Short Cervical Length","enrollment":1311},{"nctId":"NCT07214311","phase":"PHASE2, PHASE3","title":"Evaluation of PLG0206 in Prevention of Recurrent Infection in Patients Undergoing Debridement, Antibiotics, and Implant Retention (DAIR) for Treatment of a Periprosthetic Joint Infection (PJI) Following Knee Arthroplasty","status":"RECRUITING","sponsor":"Peptilogics","startDate":"2026-02-03","conditions":"Prosthetic-joint Infection","enrollment":240},{"nctId":"NCT02836899","phase":"PHASE3","title":"Effect of Nitric Oxide in Cardiac Surgery Patients With Endothelial Dysfunction.","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2017-02-08","conditions":"Acute Kidney Injury","enrollment":250},{"nctId":"NCT05730283","phase":"PHASE2","title":"Prevention of Ototoxicity in NTM Patients Treated With IV Amikacin","status":"RECRUITING","sponsor":"Kevin Winthrop","startDate":"2025-06-02","conditions":"Ototoxicity, Drug-Induced","enrollment":105},{"nctId":"NCT04373473","phase":"PHASE2","title":"Evaluation the Safety and Efficacy of Lyophilized Fecal Microbiota Transplantation Administered Orally for Prevention of Relapse or Intestinal Inflammation in Adults With Ulcerative Colitis","status":"RECRUITING","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2020-09-14","conditions":"Adults With Ulcerative Colitis","enrollment":58},{"nctId":"NCT07015905","phase":"PHASE3","title":"REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in Adults","status":"RECRUITING","sponsor":"Regeneron Pharmaceuticals","startDate":"2025-06-25","conditions":"Venous Thromboembolism (VTE)","enrollment":2000},{"nctId":"NCT06323928","phase":"PHASE2","title":"A Dose-finding Trial With Lu-AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive Treatments","status":"ACTIVE_NOT_RECRUITING","sponsor":"H. Lundbeck A/S","startDate":"2024-04-01","conditions":"Migraine","enrollment":874},{"nctId":"NCT07454408","phase":"PHASE1, PHASE2","title":"Evaluation of the Outcome of Fecal Microbiota Transplantation","status":"NOT_YET_RECRUITING","sponsor":"Air Force Military Medical University, China","startDate":"2026-03-07","conditions":"Hepatic Encephalopathy, Fecal Microbiota Transplantation, TIPS","enrollment":40},{"nctId":"NCT06039644","phase":"NA","title":"To Evaluate the Clinical Efficacy of Probiotics in Patients With the Breast Cancer","status":"RECRUITING","sponsor":"GenMont Biotech Incorporation","startDate":"2024-04-08","conditions":"Breast Cancer","enrollment":100},{"nctId":"NCT06806293","phase":"PHASE3","title":"Study of Oral Atogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine","status":"RECRUITING","sponsor":"AbbVie","startDate":"2025-02-10","conditions":"Menstrual Migraine (MM)","enrollment":430},{"nctId":"NCT07452978","phase":"PHASE2","title":"Propranolol for Early Secondary Prevention of Post-Traumatic Stress Disorder in Women Victims of Sexual Violence","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Tours","startDate":"2026-09-01","conditions":"PTSD - Post Traumatic Stress Disorder","enrollment":34},{"nctId":"NCT07341386","phase":"PHASE4","title":"Prevention of Recurrence of Herpes Simplex in Autoimmune Rheumatic Diseases","status":"NOT_YET_RECRUITING","sponsor":"University of Sao Paulo General Hospital","startDate":"2026-04-01","conditions":"Autoimmune Rheumatic Diseases, Recurrent Herpes Simplex, Prevention","enrollment":62},{"nctId":"NCT05342519","phase":"PHASE2","title":"Daily Topical Rapamycin for Vitiligo","status":"ACTIVE_NOT_RECRUITING","sponsor":"Medical University of South Carolina","startDate":"2022-07-28","conditions":"Vitiligo","enrollment":20},{"nctId":"NCT07448974","phase":"PHASE3","title":"Vitamin D and Type 2 Diabetes - Treat-To-Target","status":"NOT_YET_RECRUITING","sponsor":"Tufts Medical Center","startDate":"2026-05","conditions":"Prediabetes, Type 2 Diabetes (T2DM)","enrollment":100},{"nctId":"NCT06083623","phase":"PHASE2, PHASE3","title":"A Trial to Evaluate the Efficacy and Safety of TNM001 for the Prevention of Lower Respiratory Tract Infection Caused by Respiratory Syncytial Virus in Infants","status":"COMPLETED","sponsor":"Zhuhai Trinomab Pharmaceutical Co., Ltd.","startDate":"2023-09-11","conditions":"Respiratory Syncytial Virus Infections","enrollment":2282},{"nctId":"NCT04608630","phase":"PHASE2","title":"Bone Loss Prevention With Zoledronic Acid or Denosumab in Critically Ill Adults","status":"RECRUITING","sponsor":"Australian and New Zealand Intensive Care Research Centre","startDate":"2021-07-15","conditions":"Critical Illness, Osteoporosis","enrollment":450},{"nctId":"NCT06616194","phase":"PHASE3","title":"A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine","status":"RECRUITING","sponsor":"Pfizer","startDate":"2024-11-15","conditions":"Migraine","enrollment":200},{"nctId":"NCT06634056","phase":"PHASE2","title":"Pneumonitis Prevention Protocol Using Pentoxifylline and α-tocopherol In Stage III Non-Small Cell Lung Cancer Patients Undergoing Chemoradiation","status":"NOT_YET_RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2026-05-30","conditions":"Non-Small Cell Lung Cancer, Radiation Induced Lung Injury (RILI)","enrollment":150},{"nctId":"NCT07248280","phase":"PHASE3","title":"Adding Aprepitant to a Multimodal Strategy for the Prevention of Postoperative Nausea and Vomiting in High-risk Outpatient Surgical Patients","status":"RECRUITING","sponsor":"Centre hospitalier de l'Université de Montréal (CHUM)","startDate":"2026-02-27","conditions":"Nausea and Vomiting, Postoperative, Prevention","enrollment":260},{"nctId":"NCT06379074","phase":"NA","title":"Poor Sleep During Pregnancy as Risk Factor for Post-partum Stress and Mental Health","status":"RECRUITING","sponsor":"University of Rome G. Marconi","startDate":"2024-05-06","conditions":"Postpartum Depression, Insomnia, Stress","enrollment":114},{"nctId":"NCT00343460","phase":"PHASE3","title":"APF530 or Aloxi (Palonosetron Hydrochloride) Combined With Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Cancer","status":"COMPLETED","sponsor":"Heron Therapeutics","startDate":"2006-06","conditions":"Nausea and Vomiting, Unspecified Adult Solid Tumor, Protocol Specific","enrollment":1428},{"nctId":"NCT06563895","phase":"PHASE3","title":"Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant","status":"RECRUITING","sponsor":"Eidos Therapeutics, a BridgeBio company","startDate":"2025-05-12","conditions":"Amyloidosis, Amyloid Cardiomyopathy, Transthyretin Amyloidosis","enrollment":582},{"nctId":"NCT02106494","phase":"PHASE3","title":"A Prospective, Multicenter, Study of APF530 (Granisetron) SC for Prevention of CINV in Patients Receiving HEC","status":"COMPLETED","sponsor":"Heron Therapeutics","startDate":"2014-03","conditions":"Chemotherapy-induced Nausea and Vomiting","enrollment":942},{"nctId":"NCT07431502","phase":"PHASE3","title":"Trial to Evaluate Nonavalent HPV Vaccine as a Secondary Prevention in Patients Treated for Human Papilloma Virus Related High-grade Squamous Intraepithelial Lesions","status":"NOT_YET_RECRUITING","sponsor":"Gustave Roussy, Cancer Campus, Grand Paris","startDate":"2026-05","conditions":"Patients With Primary HPV High-grade Squamous Intra-epithelial Lesions (HSIL) at Vulvar Site, Patients With Primary HPV High-grade Squamous Intra-epithelial Lesions (HSIL) at Vaginal Site, Patients With Primary HPV High-grade Squamous Intra-epithelial Lesions (HSIL) at Penile Site","enrollment":984},{"nctId":"NCT07438262","phase":"PHASE2","title":"The AminoECMO Pilot Trial","status":"NOT_YET_RECRUITING","sponsor":"Australian and New Zealand Intensive Care Research Centre","startDate":"2026-02-01","conditions":"Acute Kidney Injury","enrollment":40},{"nctId":"NCT07022678","phase":"PHASE3","title":"Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia","status":"NOT_YET_RECRUITING","sponsor":"Children's Oncology Group","startDate":"2026-08-08","conditions":"Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia","enrollment":556},{"nctId":"NCT07232069","phase":"PHASE3","title":"PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis","status":"NOT_YET_RECRUITING","sponsor":"Duke University","startDate":"2026-07-01","conditions":"Coronary Artery Disease Risk Factors Multiple, Coronary Artery Disease Progression, Prevention & Control","enrollment":1500},{"nctId":"NCT04616326","phase":"PHASE3","title":"A Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic Migraine","status":"ACTIVE_NOT_RECRUITING","sponsor":"Eli Lilly and Company","startDate":"2020-11-25","conditions":"Chronic Migraine","enrollment":312},{"nctId":"NCT06624878","phase":"NA","title":"Esketamine for Prevention of Depression After Cytoreductive Surgery in Ovarian Cancer","status":"COMPLETED","sponsor":"Zhejiang Cancer Hospital","startDate":"2024-10-08","conditions":"Ovarian Cancer, Cytoreductive Surgery, Depressive Symptom","enrollment":568},{"nctId":"NCT07428681","phase":"PHASE4","title":"Lorazepam for Delirium Prevention in Critically Ill Patients With High Anttila-Index","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Basel, Switzerland","startDate":"2027-03","conditions":"Delirium Confusional State","enrollment":260},{"nctId":"NCT06592794","phase":"PHASE3","title":"A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ≥18 Years of Age for the Prevention of Acute Gastroenteritis","status":"ACTIVE_NOT_RECRUITING","sponsor":"ModernaTX, Inc.","startDate":"2024-09-24","conditions":"Acute Gastroenteritis, Norovirus Acute Gastroenteritis","enrollment":37864}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":375,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Placebo Preventative","genericName":"Placebo Preventative","companyName":"Benaroya Research Institute","companyId":"benaroya-research-institute","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This drug is a placebo, meaning it has no active therapeutic effect. Used for Prevention of symptoms in clinical trials.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}